Numerous serum and pathological indicators, including carcinoembryonic antigen (CEA) and TNM staging systems, have found widespread clinical application in the diagnosis, treatment guidance, and outcome prediction for patients with colorectal cancer (CRC). Here, CEACAM5 is linked to colorectal cancer.